← k velikim vlagateljem
Fairmount Funds Management LLC
upravljavec premoženja · portfelj $1.51 mrd. · 12 pozicij · poročilo na dan 30.06.2026
Pozicije v Delnicah poročilo za 30.06.2026, oddano 14.08.2026; sprememba — v primerjavi z 31.03.2026 · 13
| Podjetje | Delnice | Vrednost | % portfelja | Sprememba v Četrtletju |
|---|---|---|---|---|
| Oruka Therapeutics, Inc. US:ORKA | 3 705 262 | $353 mio. | 23.31% | — |
| Dianthus Therapeutics Inc. US:DNTH | 2 537 191 | $247 mio. | 16.35% | — |
| DAMORA THERAPEUTICS INC CUSIP 36322Q206 | 8 713 000 | $227 mio. | 14.98% | — |
| Cogent Biosciences Inc US:COGT | 5 503 418 | $213 mio. | 14.08% | — |
| Jade Biosciences, Inc. US:JBIO | 4 553 494 | $101 mio. | 6.69% | — |
| Enliven Therapeutics Inc. US:ELVN | 1 855 644 | $94.2 mio. | 6.22% | — |
| Viridian Therapeutics Inc US:VRDN | 5 090 928 | $93.5 mio. | 6.18% | +1 176 470 |
| Zenas BioPharma, Inc. US:ZBIO | 2 359 025 | $59.9 mio. | 3.96% | — |
| CRESCENT BIOPHARMA INC. CUSIP G2545C104 | 2 747 866 | $49.5 mio. | 3.27% | — |
| APOGEE THERAPEUTICS INC CUSIP 03770N101 | 298 647 | $39.6 mio. | 2.62% | — |
| Faeth Therapeutics, Inc. US:FTH | 722 020 | $18.1 mio. | 1.19% | nova |
| Inhibikase Therapeutics Inc US:IKT | 8 625 000 | $17.5 mio. | 1.16% | — |
| Spyre Therapeutics Inc. US:SYRE | 0 (bilo je 4 018 101) | — | — | prodana |
V podjetjih iz naše baze podatkov 1
| Podjetje | Delež | Delnice | Datum Poročila |
|---|---|---|---|
| Viridian Therapeutics Inc | 4.49% | 5 090 928 | 2026-06-30 |
oglas